Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
Aim. A review of current therapeutic perspectives of the herbal STW 5 medicine (Iberogast®) in functional gastrointestinal (GI) diseases.Key points. A limited remediation in most common functional GI diseases, functional dyspepsia (FD) and irritable bowel syndrome (IBS), is conditioned by their mult...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2022-01-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860047197765632 |
|---|---|
| author | A. A. Sheptulin |
| author_facet | A. A. Sheptulin |
| author_sort | A. A. Sheptulin |
| collection | DOAJ |
| description | Aim. A review of current therapeutic perspectives of the herbal STW 5 medicine (Iberogast®) in functional gastrointestinal (GI) diseases.Key points. A limited remediation in most common functional GI diseases, functional dyspepsia (FD) and irritable bowel syndrome (IBS), is conditioned by their multifactorial pathogenesis. Meanwhile, most specific medicines only target selected pathogenesis components, thus warranting a multitarget agent development. Such is Iberogast® that acts at variant components of FD and IBS pathogenesis. The article reviews the Iberogast® mechanisms of action and evaluates its treatment efficacy in FD and IBS.Conclusion. The current evidence claims that Iberogast® provides an effective and safe treatment for FD and IBS. |
| format | Article |
| id | doaj-art-619b0df13d5a45abaec3c2f6395a72ae |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2022-01-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-619b0df13d5a45abaec3c2f6395a72ae2025-02-10T16:14:37ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732022-01-01315616510.22416/1382-4376-2021-31-5-61-65448Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal DiseasesA. A. Sheptulin0Sechenov First Moscow State Medical University (Sechenov University)Aim. A review of current therapeutic perspectives of the herbal STW 5 medicine (Iberogast®) in functional gastrointestinal (GI) diseases.Key points. A limited remediation in most common functional GI diseases, functional dyspepsia (FD) and irritable bowel syndrome (IBS), is conditioned by their multifactorial pathogenesis. Meanwhile, most specific medicines only target selected pathogenesis components, thus warranting a multitarget agent development. Such is Iberogast® that acts at variant components of FD and IBS pathogenesis. The article reviews the Iberogast® mechanisms of action and evaluates its treatment efficacy in FD and IBS.Conclusion. The current evidence claims that Iberogast® provides an effective and safe treatment for FD and IBS.https://www.gastro-j.ru/jour/article/view/650functional dyspepsiairritable bowel syndromeiberogast® |
| spellingShingle | A. A. Sheptulin Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases Российский журнал гастроэнтерологии, гепатологии, колопроктологии functional dyspepsia irritable bowel syndrome iberogast® |
| title | Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases |
| title_full | Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases |
| title_fullStr | Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases |
| title_full_unstemmed | Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases |
| title_short | Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases |
| title_sort | current prospects of herbal stw 5 agent in treatment of functional gastrointestinal diseases |
| topic | functional dyspepsia irritable bowel syndrome iberogast® |
| url | https://www.gastro-j.ru/jour/article/view/650 |
| work_keys_str_mv | AT aasheptulin currentprospectsofherbalstw5agentintreatmentoffunctionalgastrointestinaldiseases |